Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
The Journal of Infectious Diseases
|
June 6, 2000
Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease
H Rosen, J B Muhlestein, J Bartlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 2018
Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease
Yang Zhou, Chuan Hua He, Daniel S Yang, et al.
Respiratory Medicine and Research
|
June 1, 2025
Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD
Bess M Flashner, Ryosuke Imai, Andrew J Synn, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 19, 2022
CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis
Yueming Cao, Jahnavi Rudrakshala, River Williams, et al.
Respiratory Medicine and Research
|
April 18, 2025
Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease
Bess M Flashner, Ryosuke Imai, Andrew J Synn, et al.
Chest
|
June 8, 2025
Anti-Ro52 Seropositive Interstitial Lung Disease Is Associated With a Higher Risk of Disease Progression and Mortality
Ryosuke Imai, Rene S Bermea, Sophia H Zhao, et al.
Controlled Clinical Trials
|
February 1, 1996
Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project
L Gorkin, E B Schron, K Handshaw, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 11, 2024
Endobronchial Optical Coherence Tomography as a Novel Method for <i>In Vivo</i> Microscopic Assessment of Interstitial Lung Abnormalities
Lida P Hariri, Amita Sharma, Sreyankar Nandy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 24, 2016
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis
Katharine E Black, Evgeny Berdyshev, Gretchen Bain, et al.
JCI Insight
|
May 5, 2017
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
Barry S Shea, Clemens K Probst, Patricia L Brazee, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
The Journal of Infectious Diseases
|
June 6, 2000
Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease
H Rosen, J B Muhlestein, J Bartlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 2018
Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease
Yang Zhou, Chuan Hua He, Daniel S Yang, et al.
Respiratory Medicine and Research
|
June 1, 2025
Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD
Bess M Flashner, Ryosuke Imai, Andrew J Synn, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 19, 2022
CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis
Yueming Cao, Jahnavi Rudrakshala, River Williams, et al.
Respiratory Medicine and Research
|
April 18, 2025
Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease
Bess M Flashner, Ryosuke Imai, Andrew J Synn, et al.
Chest
|
June 8, 2025
Anti-Ro52 Seropositive Interstitial Lung Disease Is Associated With a Higher Risk of Disease Progression and Mortality
Ryosuke Imai, Rene S Bermea, Sophia H Zhao, et al.
Controlled Clinical Trials
|
February 1, 1996
Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project
L Gorkin, E B Schron, K Handshaw, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 11, 2024
Endobronchial Optical Coherence Tomography as a Novel Method for <i>In Vivo</i> Microscopic Assessment of Interstitial Lung Abnormalities
Lida P Hariri, Amita Sharma, Sreyankar Nandy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 24, 2016
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis
Katharine E Black, Evgeny Berdyshev, Gretchen Bain, et al.
JCI Insight
|
May 5, 2017
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
Barry S Shea, Clemens K Probst, Patricia L Brazee, et al.
Page
of 22